CEUCX | FTADX | CEUCX / FTADX | |
Total Expense Ratio | 1.63 | 1.12 | 146% |
Annual Report Gross Expense Ratio | 1.63 | 1.12 | 146% |
Fund Existence | 23 years | 21 years | - |
Gain YTD | 12.426 | 18.434 | 67% |
Front Load | N/A | 4% | - |
Min. Initial Investment | 250 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 134B | 11.3B | 1,186% |
Annual Yield % from dividends | 0.12 | 1.98 | 6% |
Returns for 1 year | 4.09 | 14.37 | 28% |
Returns for 3 years | 27.52 | 51.51 | 53% |
Returns for 5 years | 12.95 | 34.03 | 38% |
Returns for 10 years | 24.68 | 46.83 | 53% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
SPYC | 42.50 | 1.11 | +2.69% |
Simplify US Equity PLUS Convexity ETF | |||
JMOM | 64.62 | 0.66 | +1.03% |
JPMorgan US Momentum Factor ETF | |||
SPXX | 17.97 | 0.13 | +0.73% |
Nuveen S&P 500 Dynamic Overwrite Fund | |||
BBC | 20.32 | 0.13 | +0.65% |
Virtus LifeSci Biotech Clinical Trls ETF | |||
EFFE | 21.87 | N/A | N/A |
Harbor Osmosis Emerging Markets Resource Efficient ETF |